Tokyo, Nov. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059524) titled 'Research on itch sensitivity' on Nov. 1.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Self control
Primary Sponsor:
Institute - Juntendo University
Condition:
Condition - Sebum deficiency, skin disease, or diseases accompanied by itching
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - In order to clarify the cause of itch sensitivity, the correlation between itch levels (spontaneous itch and mechanical alloknesis) and dryness levels, and further clarify what disease factors are involved in itch sensitivity.
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - Topical application of menthol (single application on dry or normal skin)
Eligibility:
Age-lower limit - 20
years-old
=
Gender - Male and Female
Key inclusion criteria - Normal subjects (those without skin diseases that cause itching) and those with sebum deficiency, skin diseases, or itching
Key exclusion criteria - Those with hypersensitivity to menthol or its components, areas with active lesions of dermatitis, pregnant or lactating women, etc.
Target Size - 120
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2020 Year 11 Month 02 Day
Date of IRB - 2020 Year 12 Month 02 Day
Anticipated trial start date - 2021 Year 04 Month 06 Day
Last follow-up date - 2026 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068089
Disclaimer: Curated by HT Syndication.
